Vaccine

The filing for sitagliptin tablets in three strengths marks Morepen's entry into integrated finished-dose development and regulatory filings in the US market

Initial QDENGA doses for India to come from Germany; private-market launch planned in H1 2027

Grouping eyes more collaboration on treatment TB, NCD and mental health

Drug regulator flags a batch of widely used Abhayrab rabies vaccine as substandard and potentially spurious after it failed a potency test, a government document shows

Today's opinions examine India's climate diplomacy lessons, vaccine resistance amid medical advances, AI's real-world limitations, RSS outreach to Gen Z and the growing threat of cognitive warfare

Flaws in US vaccine policy could make it impossible to leverage technology in optimal ways to advance medical science

The adulation served to marginalise the contributions of others, none more so than Albert Sabin, whose competing polio vaccine proved essential in controlling the disease

India has approved its first dengue vaccine. Japan-based Takeda's *QDENGA* is now approved for people aged *4 to 60 years* and protects against all four dengue virus serotypes.

The vaccine has been approved for individuals aged 4-60 years and can be administered without prior dengue screening, marking India's first vaccine-based strategy against the disease

The agreement positions the Pune-based vaccine maker to manufacture the M72/AS01E TB vaccine candidate at scale if ongoing Phase III trials succeed and approvals are secured

A personalised mRNA vaccine may help the immune system fight pancreatic cancer for years, with early trial data showing reduced recurrence in some patients

With dengue rising across regions, doctors break down the vaccine's benefits, safety, and why mosquito control still remains essential

A federal judge in Boston has temporarily blocked federal health officials from cutting the number of vaccines recommended for every child, and says U.S. Health Secretary Robert F. Kennedy Jr. likely violated federal procedures in revamping a key vaccine advisory committee. The decision Monday halts an order by Kennedy - announced in January - to end broad recommendations for all children to be vaccinated against flu, rotavirus, hepatitis A, hepatitis B, some forms of meningitis and RSV. Leading medical groups voiced alarm at the changes. The American Academy of Pediatrics and some other groups amended a lawsuit filed in July, asking the judge to stop the government from scaling back the nation's childhood vaccination schedule. The judge also says Kennedy's reconstitution of the vaccine advisory panel likely violated federal law. He ordered the appointments - and all decisions made by the reformed committee - put on hold.

A new study in mice explores a nasal vaccine approach that could offer broad protection against respiratory infections

Richard Hatchett, who leads the Cepi, a partnership of governments and philanthropies that was among the first to fund Covid-19 vaccines, said epidemics and pandemics remained a key global threat

Oral polio vaccines (OPVs) are safe, effective and central to global eradication efforts, but there is a need for improved immunisation to combat the emergence of vaccine-derived poliovirus strains, a US-based public health expert said. Referring to India's current status, Gates Foundation Deputy Director Dr Ananda Sankar Bandyopadhyay said paralytic outbreaks from circulating strains of variant polioviruses have not been detected in recent years, an indication that the country has been able to "maintain high routine immunisation coverage". Notably, India was certified polio-free in March 2014. "Oral polio vaccines (OPVs) are safe, effective, affordable, and easy to deliver. Use of OPV through routine immunisation and mass vaccination campaigns has eliminated poliovirus transmission and prevented paralysis in children across the world, with 99.9 per cent of the world polio-free," Bandyopadhyay told PTI from Seattle, USA. He said variant strains primarily emerge in areas with weak .

A Nipah vaccine developed at the University of Tokyo is set to enter human trials in April, as India reports fresh cases of the deadly virus that currently has no approved treatment

New US research links the shingles vaccine to lower inflammation and slower biological ageing in later life, suggesting adult vaccination may support healthier ageing beyond infection prevention

The findings add to growing evidence supporting vaccine safety, showing no higher epilepsy risk among children who received routine immunisations

The company said Hevaxin is the only hepatitis E vaccine approved by the Drug Controller General of India (DCGI) and is indicated for active immunisation against HEV infection